Intranasal dexmedetomidine and intravenous ketamine for procedural sedation in a child with alpha-mannosidosis: a magic bullet?
Ital J Pediatr
; 45(1): 119, 2019 Sep 03.
Article
em En
| MEDLINE
| ID: mdl-31481093
ABSTRACT
BACKGROUND:
Procedural sedation is increasingly needed in pediatrics. Although different drugs or drugs association are available, which is the safest and most efficient has yet to be defined, especially in syndromic children with increased sedation-related risk factors. CASE REPORT we report the case of a five-year-old child affected by alpha-mannosidosis who required procedural sedation for an MRI scan and a lumbar puncture. We administered intranasal dexmedetomidine (4 µg/kg) 45 min before intravenous cannulation, followed by one bolus of ketamine (1 mg/kg) for each procedure. The patient maintained spontaneous breathing and no desaturation or any complication occurred.CONCLUSION:
intranasal dexmedetomidine and intravenous ketamine could be a feasible option for MRI and lumbar puncture in children with alpha-mannosidosis needing sedation.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dexmedetomidina
/
Hipnóticos e Sedativos
/
Ketamina
/
Anestésicos Dissociativos
/
Alfa-Manosidose
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article